FOXM1 and obstructive sleep apnea syndrome: In this study, in vitro treatment of AC16 cardiomyocytes with OSA-exo significantly upregulated FOXM1 expression, enhanced cell viability, and reduced apoptosis, supporting a potential compensatory cardioprotective mechanism mediated by exosomal signaling.